Heart Transplantation for Chagas Cardiomyopathy

Journal of Heart and Lung Transplantation

Volumn 36, Issue 6, 2017, Pages 597-603

  Benatti, Rodolfo D ^a   Oliveira, Guilherme H ^a   Bacal, Fernando ^b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Benznidazole; Chagas cardiomyopathy; heart transplant; immunosuppression; T. cruzi reactivation

Indexed keywords

ARTICLE; ASSISTED CIRCULATION; CHAGAS CARDIOMYOPATHY; CHAGAS DISEASE; FEASIBILITY STUDY; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HEALTH CARE COST; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HUMAN; MALIGNANT NEOPLASM; PRIORITY JOURNAL; SOUTH AMERICA; SOUTH AMERICAN; VASCULAR DISEASE; ANIMAL; COMPLICATION; ISOLATION AND PURIFICATION; PARASITOLOGY; PROCEDURES; TRYPANOSOMA CRUZI;

ANIMALS; CHAGAS CARDIOMYOPATHY; CHAGAS DISEASE; HEART TRANSPLANTATION; HUMANS; TRYPANOSOMA CRUZI;

EID: 85015645131     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2017.02.006     Document Type: Article

References (56)

1. 1 Huprikar, S., Bosserman, E., Patel, G., et al. Donor-derived Trypanosoma cruzi infection in solid organ recipients in the United States, 2001-2011. Am J Transplant 13 (2013), 2418–2425.
2. 2 Rassi, A. Jr, Rassi, A., Marin-Neto, J.A., Chagas disease. Lancet 375 (2010), 1388–1402.
3. 3 Bern, C., Montgomery, S.P., An estimate of the burden of Chagas disease in the United States. Clin Infect Dis 49 (2009), 52–54.
4. 4 Canesin, M.F., Giorgi, D., Oliveira, M.T., et al. Ambulatory blood pressure monitoring of patients with heart failure. A new prognosis marker. Arq Bras Cardiol 78 (2002), 83–89.
5. 5 Freitas, H.F., Chizzola, P.R., Paes, A.T., et al. Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas’ heart disease. Int J Cardiol 102 (2005), 239–247.
6. 6 Bestetti, R.B., Role of parasites in the pathogenesis of Chagas’ cardiomyopathy. Lancet 347 (1996), 913–914.
7. 7 Riarte, A., Luna, C., Sabatiello, R., et al. Chagas’ disease in patients with kidney transplants: 7 years of experience 1989–1996. Clin Infect Dis 29 (1999), 561–567.
8. 8 Fiorelli, A.I., Santos, R.H., Oliveira, J.L. Jr, et al. Heart transplantation in 107 cases of Chagas’ disease. Transplant Proc 43 (2011), 220–224.
9. 9 Abuhab, A., Trindade, E., Aulicino, G.B., et al. Chagas’ cardiomyopathy: the economic burden of an expensive and neglected disease. Int J Cardiol 168 (2013), 2375–2380.
10. 10 Issa, V.S., Amaral, A.F., Cruz, F.D., et al. Beta-blocker therapy and mortality of patients with Chagas cardiomyopathy: a subanalysis of the REMADHE prospective trial. Circ Heart Fail 3 (2010), 82–88.
11. 11 Nunes, M.C.P., Barbosa, M.M., Brum, V.A.A., et al. Morphofunctional characteristics of the right ventricle in Chagas’ dilated cardiomyopathy. Int J Cardiol 94 (2004), 79–85.
12. 12 Mady, C., Cardoso, R.H., Barreto, A.C.P., et al. Survival and predictors of survival in patients with congestive heart failure due to Chagas’ cardiomyopathy. Circulation 90 (1994), 3098–3102.
13. 13 Rassi, A. Jr, Rassi, A., Little, W.C., et al. Development and validation of a risk score for predicting death in Chagas’ heart disease. N Engl J Med 355 (2006), 799–808.
14. 14 Cardinalli-Neto, A., Bestetti, R.B., Cordeiro, J.A., et al. Predictors of all-cause mortality for patients with chronic Chagas’ heart disease receiving implantable cardioverter-defibrillator therapy. J Cardiovasc Electrophysiol 18 (2007), 1236–1240.
15. 15 Mehra, M.R., Canter, C.E., Hannan, M.M., et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. J Heart Lung Transplant 35 (2016), 1–23.
16. 16 Bertolino, N.D., Villafanha, D.F., Cardinalli-Neto, A., et al. Prognostic impact of Chagas’ disease in patients awaiting heart transplantation. J Heart Lung Transplant 29 (2010), 449–453.
17. 17 Dib, J.A., Bestetti, R.B., Freitas, P.F., et al. Predictors of all-cause mortality for patients with Chagas’ cardiomyopathy listed for heart transplantation. Int J Cardiol 136 (2009), 162–164.
18. 18 Chin-Hong, P.V., Schwartz, B.S., Bern, C., et al. Screening and treatment of Chagas disease in organ transplant recipients in the United States: recommendations from the Chagas in Transplant Working Group. Am J Transplant 11 (2011), 672–680.
19. 19 WHO Expert Committee on the Control of Chagas Disease. Control of Chagas disease: Second report of the WHO expert committee. 2002, World Health Organization, Geneva.
20. 20 Schwartz, B.S., Mawhorter, S.D., Parasitic infections in solid organ transplantation. Am J Transplant 13 (2013), 280–303.
21. 21 Prata, A., Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 1 (2001), 92–100.
22. 22 Andrade, S.G., Magalhães, J.B., Biodemes and zymodemes of Trypanosoma cruzi strains: correlations with clinical data and experimental pathology. Rev Soc Bras Med Trop 30 (1997), 27–35.
23. 23 Souza, D.H., Vaz Mda, G., Fonseca, C.R., et al. Current epidemiological profile of Chagasic megaesophagus in Central Brazil. Rev Soc Bras Med Trop 46 (2013), 316–321.
24. 24 Bocchi, E.A., Heart transplants for patients with Chagas’ heart disease. Sao Paulo Med J 113 (1995), 873–879.
25. 25 Pantanali, C.A., Herbella, F.A., Henry, M.A., et al. Laparoscopic Heller myotomy and fundoplication in patients with Chagas’ disease achalasia and massively dilated esophagus. Am Surg 79 (2013), 72–75.
26. 26 Moreira, L.F., Galantier, J., Benício, A., et al. Left ventricular circulatory support as bridge to heart transplantation in Chagas’ disease cardiomyopathy. Artif Organs 31 (2007), 253–258.
27. 27 Kransdorf, E.P., Czer, L.S., Luthringer, D.J., et al. Heart transplantation for Chagas cardiomyopathy in the United States. Am J Transplant 13 (2013), 3262–3268.
28. 28 Kransdorf, E.P., Fishbein, M.C., Czer, L.S., Pathology of chronic Chagas cardiomyopathy in the United States: a detailed review of 13 cardiectomy cases. Am J Clin Pathol 146 (2016), 191–198.
29. 29 Ruzza, A., Czer, L.S., De Robertis, M., et al. Total artificial heart as bridge to heart transplantation in Chagas cardiomyopathy: case report. Transplant Proc 48 (2016), 279–281.
30. 30 Bocchi, E.A., Bellotti, G., Uip, D., et al. Long-term follow-up after heart transplantation in Chagas’ disease. Transplant Proc 25 (1993), 1329–1330.
31. 31 Schijman, A.G., Vigliano, C., Burgos, J., et al. Early diagnosis of recurrence of Trypanosoma cruzi infection by polymerase chain reaction after heart transplantation of a chronic Chagas’ heart disease patient. J Heart Lung Transplant 19 (2000), 1114–1117.
32. 32 Diez, M., Favaloro, L., Bertolotti, A., et al. Usefulness of PCR strategies for early diagnosis of Chagas’ disease reactivation and treatment follow-up in heart transplantation. Am J Transplant 7 (2007), 1633–1640.
33. 33 Burgos, J.M., Diez, M., Vigliano, C., et al. Molecular identification of Trypanosoma cruzi discrete typing units in end-stage chronic Chagas heart disease and reactivation after heart transplantation. Clin Infect Dis 51 (2010), 485–495.
34. 34 Cura, C.I., Lattes, R., Nagel, C., et al. Early molecular diagnosis of acute Chagas disease after transplantation with organs from Trypanosoma cruzi-infected donors. Am J Transplant 13 (2013), 3253–3261.
35. 35 Teixeira, V.A.P., Araújo, M.B.M., Reis, M.A., et al. Possible role of an adrenal parasite reservoir in the pathogenesis of Trypanosoma cruzi myocarditis. Trans R Soc Trop Med Hyg 87 (1993), 552–554.
36. 36 Teixeira Vde, P., Hial, V., Gomes, R.A., et al. Correlation between adrenal central vein parasitism and heart fibrosis in chronic chagasic myocarditis. Am J Trop Med Hyg 56 (1997), 177–180.
37. 37 Gómez-Hernández, C., Rezende-Oliveira, K., Nascentes, G.A., et al. Molecular characterization of Trypanosoma cruzi Mexican strains and their behavior in the mouse experimental model. Rev Soc Bras Med Trop 44 (2011), 684–690.
38. 38 Bestetti, R.B., Theodoropoulos, T.A., A systematic review of studies on heart transplantation for patients with end-stage Chagas’ heart disease. J Card Fail 15 (2009), 249–255.
39. 39 Benvenuti, L.A., Roggério, A., Nishiya, A.S., et al. Trypanosoma cruzi persistence in the native heart is associated with high-grade myocarditis, but not with Chagas’ disease reactivation after heart transplantation. J Heart Lung Transplant 33 (2014), 698–703.
40. 40 Fiorelli, A.I., Stolf, N.A., Honorato, R., et al. Later evolution after cardiac transplantation in Chagas’ disease. Transplant Proc 37 (2005), 2793–2798.
41. 41 Bacal, F., Silva, C.P., Bocchi, E.A., et al. Mycophenolate mofetil increased Chagas’ disease reactivation in heart transplanted patients: comparison between two different protocols. Am J Transplant 5 (2005), 2017–2021.
42. 42 Campos, S.V., Strabelli, T.M.V., Amato-Neto, V., et al. Risk factors for Chagas’ disease reactivation after heart transplantation. J Heart Lung Transplant 27 (2008), 597–602.
43. 43 Godoy, H.L., Guerra, C.M., Viegas, R.F., et al. Infections in heart transplant recipients in Brazil: the challenge of Chagas’ disease. J Heart Lung Transplant 29 (2010), 286–290.
44. 44 Falkowski-Temporini, G.J., Lopes, C.R., Massini, P.F., et al. Predominance of Th1 response, increase of megakaryocytes and Kupffer cells are related to survival in Trypanosoma cruzi infected mice treated with Lycopodium clavatum. Cytokine 23:88 (2016), 57–61.
45. 45 Weigel, G., Griesmacher, A., Karimi, A., et al. Effect of mycophenolate mofetil therapy on lymphocyte activation in heart transplant recipients. J Heart Lung Transplant 21 (2002), 1074–1079.
46. 46 Ayub-Ferreira, S.M., Avila, M.S., Bacal, F., et al. Basiliximab and the risk of Chagas’ disease reactivation in heart transplanted patients. J Heart Lung Transplant 30 (2011), S146–S147.
47. 47 Bacal, F., Neto, J.D., Fiorelli, A.I., et al. II Brazilian Guidelines for Cardiac Transplantation. Arq Bras Cardiol 94 (2010), 16–76 [in Portuguese].
48. 48 Andrade, J.P., Marin Neto, J.A., Paola, A.A., et al. I Latin American Guidelines for the diagnosis and treatment of Chagas’ heart disease: executive summary. Arq Bras Cardiol 96 (2011), 434–442.
49. 49 Almeida, D.R., Carvalho, A.C., Branco, J.N., et al. Chagas’ disease reactivation after heart transplantation: efficacy of allopurinol treatment. J Heart Transplant 15 (1996), 988–992.
50. 50 Bern, C., Antitrypanosomal therapy for chronic Chagas’ disease. N Engl J Med 364 (2011), 2527–2534.
51. 51 Bocchi, E.A., Bellotti, G., Mocelin, A.O., et al. Heart transplantation for chronic Chagas’ heart disease. Ann Thorac Surg 61 (1996), 1727–1733.
52. 52 Carvalho, V.B., Souza, E.F.L., Vila, J.H.A., et al. Heart transplantation in Chagas’ disease. Circulation 94 (1996), 1815–1827.
53. 53 Bocchi, E.A., Fiorelli, A., The paradox of survival results after heart transplantation for cardiomyopathy caused by Trypanosoma cruzi. Ann Thorac Surg 71 (2001), 1833–1838.
54. 54 Chaves AT, de Assis Silva Gomes Estanislau J, Fiuza JA, et al. Immunoregulatory mechanisms in Chagas disease: modulation of apoptosis in T-cell mediated immune responses. BMC Infect Dis 2016;16:191.
55. 55 Bestetti, R.B., Souza, T.R., Lima, M.F., Theodoropoulos, T.A.D., Cordeiro, J.A., Burdmann, E.A., Effects of a mycophenolate mofetil-based immunosuppressive regimen in Chagas’ heart transplant recipients. Transplantation 84 (2007), 441–442.
56. 56 Lund, L.H., Edwards, L.B., Kucheryavaya, A.Y., et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Heart Transplantation Report—2015; Focus Theme: Early Graft Failure. J Heart Lung Transplant 34 (2015), 1244–1254.